(BAS) BASF SE - Ratings and Ratios
Chemicals, Materials, Industrial, Surface, Agricultural
BAS EPS (Earnings per Share)
BAS Revenue
Description: BAS BASF SE September 29, 2025
BASF SE (XETRA:BAS) is a global chemicals producer organized into six operating segments: Chemicals (petrochemicals and intermediates); Materials (advanced polymers, isocyanates, polyamides and inorganic basics); Industrial Solutions (polymer dispersions, resins, additives, electronic materials, antioxidants for automotive, coatings, construction, paper and energy markets); Surface Technologies (catalysts, battery materials, automotive OEM and refinish coatings, metal-service solutions); Nutrition & Care (ingredients for food, feed, pharma, cosmetics, detergents and FMCG); and Agricultural Solutions (seeds, traits, crop-protection chemicals and digital farming tools). The company also generates ancillary revenue from engineering services, equipment leasing and commodity trading.
Key recent metrics suggest a mixed performance landscape: FY 2023 reported adjusted EBITDA of €7.6 billion (≈10.5 % margin), while capex remained high at €5.5 billion as BASF invests in green-hydrogen projects and specialty-chemical capacity expansions. The segment most sensitive to macro-fuel price swings is Chemicals, which tracks European petrochemical feedstock spreads; by contrast, Nutrition & Care and Agricultural Solutions have shown relative resilience due to longer-term demand growth in health-conscious consumer products and sustainable agriculture. A primary sector driver is the ongoing shift toward higher-margin specialty chemicals and circular-economy solutions, which BASF aims to capture through its “Chemistry for a Sustainable Future” roadmap.
For a deeper dive into BASF’s valuation levers and scenario-based risk assessment, the ValueRay platform provides a structured framework that can help you test the robustness of your investment thesis.
BAS Stock Overview
| Market Cap in USD | 45,444m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception |
BAS Stock Ratings
| Growth Rating | 7.88% |
| Fundamental | 40.9% |
| Dividend Rating | 42.7% |
| Return 12m vs S&P 500 | -16.5% |
| Analyst Rating | - |
BAS Dividends
| Dividend Yield 12m | 5.18% |
| Yield on Cost 5y | 6.59% |
| Annual Growth 5y | 0.75% |
| Payout Consistency | 98.5% |
| Payout Ratio | 87.6% |
BAS Growth Ratios
| Growth Correlation 3m | -43.4% |
| Growth Correlation 12m | 28.9% |
| Growth Correlation 5y | -26.4% |
| CAGR 5y | 2.52% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.09 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.24 |
| Sharpe Ratio 12m | -1.14 |
| Alpha | -22.51 |
| Beta | 1.141 |
| Volatility | 24.75% |
| Current Volume | 1215.6k |
| Average Volume 20d | 2038.1k |
| Stop Loss | 42 (-3.2%) |
| Signal | -0.26 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (388.0m TTM) > 0 and > 6% of Revenue (6% = 3.89b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.18% (prev 21.20%; Δ -0.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 6.11b > Net Income 388.0m (YES >=105%, WARN >=100%) |
| Net Debt (21.34b) to EBITDA (7.24b) ratio: 2.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (892.5m) change vs 12m ago -0.00% (target <= -2.0% for YES) |
| Gross Margin 26.21% (prev 25.21%; Δ 1.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.90% (prev 79.17%; Δ 1.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.28 (EBITDA TTM 7.24b / Interest Expense TTM 1.16b) >= 6 (WARN >= 3) |
Altman Z'' 3.32
| (A) 0.18 = (Total Current Assets 31.90b - Total Current Liabilities 18.18b) / Total Assets 77.67b |
| (B) 0.38 = Retained Earnings (Balance) 29.75b / Total Assets 77.67b |
| (C) 0.03 = EBIT TTM 2.64b / Avg Total Assets 80.06b |
| (D) 0.66 = Book Value of Equity 29.22b / Total Liabilities 44.16b |
| Total Rating: 3.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.91
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 0.78% = 0.39 |
| 3. FCF Margin 0.72% = 0.18 |
| 4. Debt/Equity 0.74 = 2.24 |
| 5. Debt/Ebitda 2.95 = -1.69 |
| 6. ROIC - WACC (= -4.93)% = -6.16 |
| 7. RoE 1.12% = 0.09 |
| 8. Rev. Trend -73.58% = -5.52 |
| 9. EPS Trend 17.65% = 0.88 |
What is the price of BAS shares?
Over the past week, the price has changed by -0.87%, over one month by +1.90%, over three months by -3.28% and over the past year by -0.28%.
Is BASF SE a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BAS is around 41.49 EUR . This means that BAS is currently overvalued and has a potential downside of -4.4%.
Is BAS a buy, sell or hold?
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.2 | 13.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.4 | 4.7% |
BAS Fundamental Data Overview January 01, 1970
Market Cap EUR = 39.02b (39.02b EUR * 1.0 EUR.EUR)
P/E Trailing = 101.6744
P/E Forward = 14.7493
P/S = 0.6025
P/B = 1.2211
P/EG = 0.8976
Beta = 1.141
Revenue TTM = 64.77b EUR
EBIT TTM = 2.64b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.96b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.89b EUR (from shortTermDebt, last quarter)
Debt = 23.85b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.34b EUR (from netDebt column, last quarter)
Enterprise Value = 60.36b EUR (39.02b + Debt 23.85b - CCE 2.52b)
Interest Coverage Ratio = 2.28 (Ebit TTM 2.64b / Interest Expense TTM 1.16b)
FCF Yield = 0.78% (FCF TTM 468.0m / Enterprise Value 60.36b)
FCF Margin = 0.72% (FCF TTM 468.0m / Revenue TTM 64.77b)
Net Margin = 0.60% (Net Income TTM 388.0m / Revenue TTM 64.77b)
Gross Margin = 26.21% ((Revenue TTM 64.77b - Cost of Revenue TTM 47.79b) / Revenue TTM)
Gross Margin QoQ = 26.50% (prev 27.89%)
Tobins Q-Ratio = 0.78 (Enterprise Value 60.36b / Total Assets 77.67b)
Interest Expense / Debt = 1.08% (Interest Expense 257.0m / Debt 23.85b)
Taxrate = 66.14% (209.0m / 316.0m)
NOPAT = 894.3m (EBIT 2.64b * (1 - 66.14%))
Current Ratio = 1.75 (Total Current Assets 31.90b / Total Current Liabilities 18.18b)
Debt / Equity = 0.74 (Debt 23.85b / totalStockholderEquity, last quarter 32.36b)
Debt / EBITDA = 2.95 (Net Debt 21.34b / EBITDA 7.24b)
Debt / FCF = 45.59 (Net Debt 21.34b / FCF TTM 468.0m)
Total Stockholder Equity = 34.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.50% (Net Income 388.0m / Total Assets 77.67b)
RoE = 1.12% (Net Income TTM 388.0m / Total Stockholder Equity 34.69b)
RoCE = 4.92% (EBIT 2.64b / Capital Employed (Equity 34.69b + L.T.Debt 18.96b))
RoIC = 1.55% (NOPAT 894.3m / Invested Capital 57.51b)
WACC = 6.48% (E(39.02b)/V(62.88b) * Re(10.22%) + D(23.85b)/V(62.88b) * Rd(1.08%) * (1-Tc(0.66)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.01%
[DCF Debug] Terminal Value 68.31% ; FCFE base≈1.36b ; Y1≈1.20b ; Y5≈996.4m
Fair Price DCF = 14.33 (DCF Value 12.79b / Shares Outstanding 892.5m; 5y FCF grow -14.37% → 3.0% )
EPS Correlation: 17.65 | EPS CAGR: -66.15% | SUE: -0.02 | # QB: 0
Revenue Correlation: -73.58 | Revenue CAGR: -11.33% | SUE: -0.03 | # QB: 0